Neoadjuvant Toripalimab for Non-squamous NSCLC With EGFR Mutation
Conditions
- Non Squamous Non Small Cell Lung Cancer
- EGFR Positive Non-small Cell Lung Cancer
Interventions
- DRUG: Toripalimab plus Chemotherapy
Sponsor
Peking University People's Hospital
Collaborators